Tipanat 15 (Trifluridine+Tipiracil Tablet) 15mg+6.14mg

Tipanat 15 is an oral chemotherapy tablet combining trifluridine and tipiracil for colorectal cancer treatment. This 15mg+6.14mg strength formulation supports metastatic disease management. Suitable for ambient storage, it offers a convenient oral alternative to IV therapy. Buy Tipanat 15 online for metastatic colorectal cancer support.

Strength

15mg+6.14mg

Pack Size

20s

Storage

Ambient

Manufacturer / TM Owner

Nacto pharma ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tipanat 15 is prescribed for adults with metastatic colorectal cancer previously treated with other therapies. It combines trifluridine and tipiracil to slow cancer progression. This tablet form is specifically designed for patients requiring continuous treatment without frequent clinic visits. It addresses what is trifluridine tipiracil used for in advanced cancer care.

Side Effects

Patients using Tipanat 15 may experience gastrointestinal effects like nausea or diarrhea. Fatigue and decreased appetite are also commonly reported. Some users notice changes in blood cell counts, which are monitored during treatment. These effects vary by individual and should be discussed with a healthcare provider.

Precautions & Warnings

Store Tipanat 15 at room temperature away from moisture and heat. Keep out of reach of children and pets. Handle with care to avoid contamination; do not crush or split tablets unless advised. Report any unusual symptoms to a medical professional promptly.

Avoid Interactions

Tipanat 15 may interact with blood thinners, certain antibiotics, or other chemotherapy drugs. Alcohol and grapefruit products could amplify side effects. Always inform your doctor about all medications, supplements, or herbal products you are using. CYP3A4 inhibitors may affect how Tipanat 15 works.

References

Frequently Asked Questions

Tipanat 15 is used to treat metastatic colorectal cancer in adults who have received prior chemotherapy.

Store Tipanat 15 at room temperature in a dry place, away from direct sunlight and children.

Tipanat 15 can be taken with or without food, but follow your doctor’s specific instructions.

Common side effects include nausea, diarrhea, fatigue, and decreased appetite.

Tipanat 15 may be available through licensed online pharmacies with a valid prescription.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.